Cannabinoid stock for formulation products
AssigneeBetterlife Pharma Inc.
InventorsLeonid Lurya, Joseph Borovsky
Life of this patent
Estimating the term…
Abstract
Transdermal cannabinoid formulations including a versatile cannabinoid stock provided as a variety of cosmetic delivery systems providing enhanced cannabinoid absorption, and more controlled release into vascular and/or lymphatic systems for greater efficacy and a desirable subject experience. The cannabinoid stock is a substantially homogeneous concentrated stable cannabinoid emulsion characterized as a cannabinoid load capacity carrier that comprises emulsified particles of stabilized cannabinoid/lipid.
Claims1
A cannabinoid stock comprising a stabilized cannabinoid/lipid particle emulsion, wherein the lipid and the cannabinoid are present in a ratio from about 5:1 to about 1:5.
Dependencies are inferred from the claim text.